OpenURL Connection Search

Select item for more details and to access through your institution.

Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: A randomised control trial.
Published in:
Mycoses, 2024, v. 67, n. 1, p. 1, doi. 10.1111/myc.13681
By:
- Rana, Deval K.;
- Shah, Tithi S.;
- Rohit, Mansi H.;
- Patel, Nayankumar H.;
- Khadela, Avinash D.;
- Oza, Yaksh P.;
- Padhiyar, Jigna K.
Publication type:
Article
A Two-Year-Old Child with Bilateral Symmetrical Papulosquamous Lesions.
Published in:
Indian Journal of Dermatology, 2024, v. 69, n. 2, p. 198, doi. 10.4103/ijd.ijd_347_23
By:
- Lakum, Megha P.;
- Padhiyar, Jignaben K.;
- Patel, Nayankumar H.;
- Patel, Jahnvi R.
Publication type:
Article
Antiphospholipid antibodies in a patient of Lucio phenomenon presenting with the gangrene of digits.
Published in:
2021
By:
- H Patel, Nayankumar;
- Padhiyar, Jignaben Krunal;
- Patel, Tejas;
- Patel, Ani;
- Chhibber, Aseem;
- Raval, Ranjan;
- Patel, Bhagirath
Publication type:
case study
IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
Published in:
Indian Dermatology Online Journal, 2024, v. 15, n. 1, p. 1, doi. 10.4103/idoj.idoj_668_22
By:
- Patel, Nayankumar H.;
- Sardana, Kabir;
- Shenoy, Manjunath M.;
- Rengasamy, Madhu;
- Khurana, Ananta;
- Ghate, Sunil;
- Venkata, Chalam Konakanchi;
- Marfatiya, Yogesh;
- Bhunia, Deblina;
- Jayaraman, Jyothi;
- Das, Anupam;
- Jain, Akshay Kumar
Publication type:
Article

Found: 4

Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: A randomised control trial.

A Two-Year-Old Child with Bilateral Symmetrical Papulosquamous Lesions.

Antiphospholipid antibodies in a patient of Lucio phenomenon presenting with the gangrene of digits.

IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.